Cargando…

Biologic medicine inclusion in 138 national essential medicines lists

BACKGROUND: Essential medicines lists (EMLs) are intended to reflect the priority health care needs of populations. We hypothesized that biologic disease-modifying antirheumatic drugs (DMARDs) are underrepresented relative to conventional DMARDs in existing national EMLs. We aimed to survey the exte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kraus, Raphaël, Yeung, Rae S. M., Persaud, Nav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419977/ https://www.ncbi.nlm.nih.gov/pubmed/34488779 http://dx.doi.org/10.1186/s12969-021-00608-z

Ejemplares similares

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
por: Richards, Georgia C, et al.
Publicado: (2020)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

A comparison of national essential medicines lists in the Americas
por: Steiner, Liane, et al.
Publicado: (2020)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
por: Taglione, Michael Sergio, et al.
Publicado: (2021)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

Associations between essential medicines and health outcomes for cardiovascular disease
por: Steiner, Liane, et al.
Publicado: (2021)

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
por: Ally, Muhamad Z., et al.
Publicado: (2020)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

National List of Essential Medicines, 2015: Endocrinology perspective
por: Kalra, Sanjay
Publicado: (2016)

Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2017)

Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
por: Baldeh, Ayo-Oley, et al.
Publicado: (2023)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists
por: Hill, Suzanne, et al.
Publicado: (2012)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

A critical look at the national essential medicines list of India 2003
por: Manikandan, S
Publicado: (2010)

The national essential medicines list of India: Time to revise and purge the mistakes
por: Gitanjali, B
Publicado: (2010)

National List of Essential Medicines 2022 of India: Perspectives from Psychiatrists
por: Parmar, Arpit, et al.
Publicado: (2023)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Is there a case for inclusion of medicines used to manage alcohol use disorder in the World Health Organization Model List of Essential Medicines?
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2021)

The case for levetiracetam to be included in essential medicine lists
por: Singh, Gagandeep, et al.
Publicado: (2023)

Chinese Proprietary Herbal Medicine Listed in ‘China National Essential Drug List’ for Common Cold: A Systematic Literature Review
por: Chen, Wei, et al.
Publicado: (2014)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

DNA metabarcoding to unravel plant species composition in selected herbal medicines on the National List of Essential Medicines (NLEM) of Thailand
por: Urumarudappa, Santhosh Kumar J., et al.
Publicado: (2020)

The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line
por: Manikandan, S.
Publicado: (2023)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

National Essential Medicines List and policy practice: A case study of China’s health care reform
por: Tian, Xin, et al.
Publicado: (2012)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Indian Essential Medicine List for Children: Time to Revisit
por: Singhal, Shubha, et al.
Publicado: (2023)

National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment
por: Parmar, Arpit, et al.
Publicado: (2020)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Essential medicines for children: Should we focus on a priority list of medicines for the present?
por: Gitanjali, B
Publicado: (2011)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

Quantitative evaluation of essential medicines lists: the South African case study
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2016)

Cost Analysis of Different Antibiotic Brands Available in Indian Market with Reference to National List of Essential Medicines
por: Meena, Dinesh Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3nboanv459k5fi8r3vkescq2u4